AQR Capital Management’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $962K | Sell |
|
|||||
|
2025
Q1 | $1.94M | Sell |
|
|||||
|
2024
Q4 | $5.79M | Buy |
|
|||||
|
2024
Q3 | $6.17M | Buy |
|
|||||
|
2024
Q2 | $868K | Sell |
|
|||||
|
2024
Q1 | $2.34M | Buy |
|
|||||
|
2023
Q4 | $214K | Sell |
|
|||||
|
2023
Q3 | $175K | Sell |
|
|||||
|
2023
Q2 | $307K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $447K | Sell |
|
|||||
|
2022
Q3 | $967K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $519K | Sell |
|
|||||
|
2021
Q3 | $739K | Buy |
|
|||||
|
2021
Q2 | $1.19M | Sell |
|
|||||
|
2021
Q1 | $787K | Buy |
|
|||||
|
2020
Q4 | $472K | Buy |
|
|||||
|
2020
Q3 | $446K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $80K | Sell |
|
|||||
|
2019
Q4 | $160K | Hold |
|
|||||
|
2019
Q3 | $272K | Buy |
|